The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 8, 2026 | HRT Financial LP | 10% Owner | Sell(S) | 19K | $3.52 | $65K |
| Jul 7, 2026 | HRT Financial LP | 10% Owner | Sell(S) | 11K | $3.33 | $35K |
| Jul 6, 2026 | HRT Financial LP | 10% Owner | Sell(S) | 9K | $3.51 | $32K |
| Jul 2, 2026 | HRT Financial LP | 10% Owner | Buy(P) | 8K | $3.54 | $28K |
| Jul 1, 2026 | HRT Financial LP | 10% Owner | Buy(P) | 4K | $3.30 | $13K |
| Jun 30, 2026 | HRT Financial LP | 10% Owner | Buy(P) | 7K | $3.23 | $22K |
| Jun 29, 2026 | HRT Financial LP | 10% Owner | Buy(P) | 26K | $3.44 | $89K |
| Aug 8, 2025 | Lorber Timothy J. | Chief Financial Officer | Grant(A) | 29K | — | $0 |
| Aug 8, 2025 | Lorber Timothy J. | Chief Financial Officer | Grant(A) | 25K | — | $0 |
| Aug 8, 2025 | Tung Joseph | Director | Grant(A) | 29K | — | $0 |
| Aug 8, 2025 | Scorsis George | Director | Grant(A) | 29K | — | $0 |
| Aug 8, 2025 | Nabyt Oleh | Director | Grant(A) | 29K | — | $0 |
| Aug 8, 2025 | Richards Steven M | Director | Grant(A) | 29K | — | $0 |
| May 1, 2024 | Jung Mira | Chief Scientific Officer | Grant(A) | 598 | $11.28 | $7K |
| Mar 8, 2024 | Vander Hoek Michael | Chief Financial Officer | Grant(A) | 100K | — | $0 |
| Dec 13, 2023 | Brown Milton | Director | Sell(S) | 3K | $0.46 | $1K |
| Dec 13, 2023 | Jacobs Bette | Director | Sell(S) | 4K | $0.46 | $2K |
| Aug 14, 2023 | Dritschilo Anatoly | CEO and Chairman, Director, 10% Owner | Gift(G) | 2.1M | — | $0 |
| Aug 14, 2023 | Dritschilo Anatoly | CEO and Chairman, Director, 10% Owner | Gift(G) | 2.1M | — | $0 |
| Feb 15, 2023 | Brown Milton | Director | Grant(A) | 25K | — | $0 |
| Dec 29, 2022 | Senanayake Chris | Director | Sell(S) | 2K | $1.61 | $3K |
| Dec 29, 2022 | Jacobs Bette | Director | Sell(S) | 4K | $1.61 | $7K |
| Dec 29, 2022 | Jung Mira | Chief Scientific Officer | Sell(S) | 328 | $1.61 | $528 |
| Dec 29, 2022 | Rich Tyvin | Chief Medical Officer | Sell(S) | 1K | $1.61 | $2K |
| Dec 29, 2022 | Dritschilo Anatoly | CEO and Chairman, Director, 10% Owner | Sell(S) | 8K | $1.61 | $13K |
| Dec 29, 2022 | Brown Milton | Director | Sell(S) | 995 | $1.61 | $2K |
| Dec 29, 2022 | Adkins William | Insider | Sell(S) | 995 | $1.61 | $2K |
| Dec 29, 2022 | Richards Steven M | Director | Sell(S) | 995 | $1.61 | $2K |
| Dec 29, 2022 | Vander Hoek Michael | Chief Financial Officer | Sell(S) | 2K | $1.61 | $4K |
| Dec 29, 2022 | Dritschilo Peter | President and COO | Sell(S) | 4K | $1.61 | $6K |
| Sep 2, 2022 | Adkins William | Insider | Other(J) | 139K | — | — |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-04-26 → 2026-07-11. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).